Cargando…
Increasing N-acetylaspartate in the Brain during Postnatal Myelination Does Not Cause the CNS Pathologies of Canavan Disease
Canavan disease is caused by mutations in the gene encoding aspartoacylase (ASPA), a deacetylase that catabolizes N-acetylaspartate (NAA). The precise involvement of elevated NAA in the pathogenesis of Canavan disease is an ongoing debate. In the present study, we tested the effects of elevated NAA...
Autores principales: | Appu, Abhilash P., Moffett, John R., Arun, Peethambaran, Moran, Sean, Nambiar, Vikram, Krishnan, Jishnu K. S., Puthillathu, Narayanan, Namboodiri, Aryan M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454052/ https://www.ncbi.nlm.nih.gov/pubmed/28626388 http://dx.doi.org/10.3389/fnmol.2017.00161 |
Ejemplares similares
-
N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation
por: Moffett, John R., et al.
Publicado: (2013) -
Acss2 Deletion Reveals Functional Versatility via Tissue-Specific Roles in Transcriptional Regulation
por: Vasudevan, Narayanan Puthillathu, et al.
Publicado: (2023) -
Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease
por: Arun, Peethambaran, et al.
Publicado: (2010) -
Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD(+) Synthesis During Inflammation and Infection
por: Moffett, John R., et al.
Publicado: (2020) -
Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy
por: von Jonquieres, Georg, et al.
Publicado: (2017)